NOVEL MUTATOR PHENOTYPES IMPORTANT IN HUMAN COLON CANCER
在人类结肠癌中重要的新突变表型
基本信息
- 批准号:2654187
- 负责人:
- 金额:$ 38.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-04-15 至 2001-01-31
- 项目状态:已结题
- 来源:
- 关键词:DNA repair carcinogenesis clinical research colon neoplasms environment related neoplasm /cancer gene complementation gene mutation genetic mapping genetic markers human genetic material tag human subject lymphocyte molecular oncology neoplasm /cancer diagnosis neoplasm /cancer genetics nucleic acid sequence oncogenes phenotype tissue /cell culture transfection
项目摘要
DESCRIPTION: (Applicant's Abstract) The goal of this application is to
define the molecular mechanisms and the role in human colon
carcinogenesis of three newly defined and genetically distinct colon
cancer "mutator" phenotypes. The applicant has detected these mutator
type colon cancers by demonstrating that these cancers have 10-100 fold
elevations in their rates of generating spontaneous hprt gene mutations.
Two of these phenotypes (comprising six cell lines) are novel, and do
not result from defects in previously described DNA mismatch-repair
genes. These findings add to earlier studies of mutator mechanisms in
colon cancer which the applicant and collaborators have demonstrated that
(1) the Hereditary Non-Polyposis Colon Cancer (HNPCC) syndrome is due
to inheritance of defective members of the DNA mismatch repair pathway
(MMR genes); (2) tumors with MMR gene defects typically display
instability of DNA microsatellites (RER tumors); (3) RER cancers also
occur among many sporadic cancers, in which case MMR genes are
unexpectedly wild type. Thus the applicant proposes that novel RER
phenotype cancers are generated by defects not involving any of the
known MMR genes. The applicant's studies also demonstrate a second novel
mutator mechanism which induces sequence instability in non-RER colon
cancers. Work by the applicant also demonstrates that genomic
instability in RER and non-RER mutator type tumors is global, inducing
hypermutability in expressed genes, as opposed to affecting only
generally non-coding microsatellites. The applicant proposes six
specific aims: (1) to characterize the specificity of DNA sequences
targeted and the sequence spectrum of the spontaneous mutations produced
by each of the three mutator phenotypes; (2) to determine the number of
complementation groups accounting for the novel mutator phenotypes, and
to map the defects inducing these phenotypes to individual chromosomes;
(3) to elucidate the susceptibility to specific classes of environmental
mutagens of each of the three mutator phenotypes; (4) to determine the
relative frequency in Non-RER colon cancer of the novel Non-RER mutator
phenotype; (5) to determine whether a transfected wild type DNA repair
gene will correct the mutator phenotype and will suppress any other
aspect of the transformed phenotype upon transfer into mutator cancer
cell lines lacking the wild type gene; and (6) to determine if gene line
defects in colon cancer mutator genes can be detected by an increased
mutation rate in the patient's lymphocytes.
描述:(申请人摘要)本申请的目标是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANFORD D. MARKOWITZ其他文献
SANFORD D. MARKOWITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANFORD D. MARKOWITZ', 18)}}的其他基金
Chemical, Structural and Cell-Signaling Interrogation of 15-Prostanglandin Dehydrogenase in Tissue Repair and Regeneration
15-前列腺素脱氢酶在组织修复和再生中的化学、结构和细胞信号传导研究
- 批准号:
10627860 - 财政年份:2021
- 资助金额:
$ 38.33万 - 项目类别:
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
针对癌症风险、预防和治疗中的 15-前列腺素脱氢酶 (15-PGDH)
- 批准号:
9406781 - 财政年份:2016
- 资助金额:
$ 38.33万 - 项目类别:
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
针对癌症风险、预防和治疗中的 15-前列腺素脱氢酶 (15-PGDH)
- 批准号:
10524057 - 财政年份:2016
- 资助金额:
$ 38.33万 - 项目类别:
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
针对癌症风险、预防和治疗中的 15-前列腺素脱氢酶 (15-PGDH)
- 批准号:
10305660 - 财政年份:2016
- 资助金额:
$ 38.33万 - 项目类别:
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
针对癌症风险、预防和治疗中的 15-前列腺素脱氢酶 (15-PGDH)
- 批准号:
9183207 - 财政年份:2016
- 资助金额:
$ 38.33万 - 项目类别:
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
针对癌症风险、预防和治疗中的 15-前列腺素脱氢酶 (15-PGDH)
- 批准号:
10058813 - 财政年份:2016
- 资助金额:
$ 38.33万 - 项目类别:
Role of gene enhancer elements in colon cancer
基因增强子元件在结肠癌中的作用
- 批准号:
8449075 - 财政年份:2012
- 资助金额:
$ 38.33万 - 项目类别:
Role of gene enhancer elements in colon cancer
基因增强子元件在结肠癌中的作用
- 批准号:
8289140 - 财政年份:2012
- 资助金额:
$ 38.33万 - 项目类别:
Role of gene enhancer elements in colon cancer
基因增强子元件在结肠癌中的作用
- 批准号:
8633432 - 财政年份:2012
- 资助金额:
$ 38.33万 - 项目类别:
Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and Prevention
以 15-PGDH 为靶点进行结肠癌的预后、预测、治疗和预防
- 批准号:
8555227 - 财政年份:2011
- 资助金额:
$ 38.33万 - 项目类别:
相似海外基金
Prevention of Radiation-Induced Carcinogenesis by Senolytics
通过 Senolytics 预防辐射诱发的致癌作用
- 批准号:
23H03539 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of Prostaglandin D Receptor-mediated Carcinogenesis Mechanism of Colitic Cancer
前列腺素D受体介导的结肠癌致癌机制的阐明
- 批准号:
23K08219 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
- 批准号:
23K05734 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
- 批准号:
10709135 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Pathways of Injury and Repair in Barrett's Carcinogenesis
巴雷特癌发生过程中的损伤和修复途径
- 批准号:
10713938 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Spatial transcriptomic research on carcinogenesis and progression of lung cancer with interstitial pneumonia
肺癌合并间质性肺炎发生发展的空间转录组学研究
- 批准号:
23K14468 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER
结对卓越,战略性地推进致癌和癌症研究
- 批准号:
10050740 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别:
EU-Funded
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
骨髓细胞驱动胰腺可塑性和致癌机制
- 批准号:
10607213 - 财政年份:2023
- 资助金额:
$ 38.33万 - 项目类别: